University of Colorado, Denver

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).

1,283 total trials 265 currently recruiting 830 completed early-phase tilt top decile by trial count

University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.

University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.

Top-decile sponsor footprint

University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 68/100

830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,283 total, page 21 of 26

COMPLETED NA

Heart Failure Management Program Versus Usual Care

NCT01822912

COMPLETED

Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures

NCT02736708

COMPLETED NA

Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma

NCT01711879

COMPLETED Phase 2

Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

NCT01743859

COMPLETED Phase 4

Pharmacokinetics of Preoperative Vancomycin

NCT03453684

COMPLETED Phase 4

Role of Mobile Technology to Improve Diabetes Care in Adults With Type 1 Diabetes: the REMOTE-T1D Study, a Pilot Study

NCT01825382

COMPLETED Phase 2

Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder

NCT01745497

COMPLETED Phase 1

Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1

NCT01758744

COMPLETED Phase 1

Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123

NCT02278198

TERMINATED NA

Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection

NCT01608919

COMPLETED Phase 1

Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History

NCT01758731

COMPLETED NA

Outcomes Following Tourniquet and Non-Tourniquet Assisted Total Knee Arthroplasty

NCT02203045

COMPLETED NA

Adolescent Vaccination Reminder Study

NCT01732315

COMPLETED NA

Shared Medical Appointments to Improve Outcomes in Adolescents With Type 1 Diabetes

NCT02547311

COMPLETED NA

Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial)

NCT01698086

COMPLETED NA

Absorption of Zinc (Zn) From Zn-biofortified and Zn-fortified Maize in Young Zambian Children Between 24-36 Months

NCT02208635

COMPLETED NA

Females, Aging, Metabolism, and Exercise

NCT01712230

COMPLETED

Continuous Noninvasive Method for Estimating and Predicting Maternal and Fetal Hemodynamic Changes During Regional Anesthesia

NCT01699243

COMPLETED NA

Strength and Function Following Total Hip Arthroplasty

NCT01817010

COMPLETED NA

Immunization Delivery in Obstetrics and Gynecology Settings

NCT01565135

COMPLETED Phase 2

Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults

NCT01685372

COMPLETED NA

Effect of a Culturally-based Intervention on Sexual Risky Behavior Among Young American Indian Adolescents

NCT01698073

COMPLETED NA

Comparative Effectiveness Trial of Two Reminder/Recall Methods to Increase Immunization Rates in Young Children

NCT01557621

COMPLETED NA

Adherence Intervention to Promote Optimal Use of Insulin Pumps in Adolescents With Type 1 Diabetes

NCT02333539

COMPLETED NA

The Role of No-Calorie Beverages Within a Weight Loss Program

NCT01766700

COMPLETED

Estimating and Predicting Hemodynamic Changes During Hemodialysis

NCT01700465

COMPLETED NA

Bundling and Unbundling the Laparoscopic Electrosurgery Cord With the Camera Cord

NCT01707095

TERMINATED NA

Jet Injection of 1% Buffered Lidocaine Versus Topical EMLA for Local Anesthesia Before Lumbar Puncture in Children

NCT01628874

COMPLETED NA

Apoyo Con Carino: Patient Navigation for Palliative Care

NCT01695382

COMPLETED NA

Adolescent Vaccination in the Medical Home: Established and Innovative Strategies

NCT01577979

COMPLETED Phase 4

Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)

NCT01663103

COMPLETED NA

Preoperative Gabapentin for Post-tonsillectomy Pain in Children

NCT01707420

COMPLETED NA

Adolescent Vaccination Kiosk Project

NCT01622608

COMPLETED

Breast Milk and Infant Growth Among Lean, Overweight and Diabetic Mothers

NCT01693406

COMPLETED Phase 4

Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease

NCT02366845

COMPLETED NA

Emergency Department (ED) Drug Interaction in Emergency Department Patients

NCT01859715

COMPLETED NA

Type 2 Diabetes and Exercise Function in Single Leg Exercises

NCT01793909

COMPLETED NA

Study in Parkinson's Disease of Exercise

NCT01506479

COMPLETED

Functional Connectivity in Primary Focal Dystonia

NCT01761903

COMPLETED NA

Barriers to Physical Activity in People With Type 2 Diabetes

NCT01701570

COMPLETED

Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure

NCT01779778

COMPLETED NA

Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression

NCT01613131

COMPLETED NA

Study of Psychological and Motor Effects of Testosterone in Adolescents With XXY/Klinefelter Syndrome

NCT01585831

COMPLETED NA

Aspiration in Acute Respiratory Failure Survivors

NCT02363686

COMPLETED Phase 2

Comparison of Rituximab Induction Therapy Followed by Glatiramer Acetate

NCT01569451

COMPLETED NA

Zinc Bioavailability From Amaranth-enriched Maize Tortillas

NCT02208609

COMPLETED

Measuring Free-living Energy Expenditure Using Direct Calorimetry

NCT01454882

COMPLETED Phase 2

Validation of a Clinical Prediction Rule to Identify Patients With Shoulder Pain Likely to Benefit From Cervicothoracic Manipulation: A Randomized Clinical Trial

NCT01571674

COMPLETED

Pediatric Optimization of the PharmaJet Needle-Free Intradermal Delivery System

NCT01494571

COMPLETED NA

Sweat Evaporimeter Measurement

NCT01708655

← Previous Page 21 of 26 Next →

Phase Distribution

PhaseTrial count
Phase 1 114
Phase 2 131
Phase 3 37
Phase 4 84

What is open in the University of Colorado, Denver pipeline

265 recruiting of 1,283 indexed (21% open); 830 completed (65%).

Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).

Top condition: Obesity (23 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Colorado, Denver: open-pipeline peers nationwide

Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 5%10%15%20%25% Total trials Recruiting share University of Colorado, DenverAstraZenecaUniversity of MichiganUniversity of PittsburghEli Lilly and CompanyCedars-Sinai Medical CenterCraig HospitalW.L.Gore & AssociatesGeorgia Institute of Technology
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,283 trials (± recruiting share)

Sponsors near 21% open enrollment (± trial volume)

What to do with this University of Colorado, Denver page

1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.

  • 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.